Covid-19 Impact on Global Urinary Tract Infection (UTI) Market Size, Status and Forecast 2020-2026

July 2020 | 130 pages | ID: CE4DD7DF3950EN
QYResearch

Abstracts

This report focuses on the global Urinary Tract Infection (UTI) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Urinary Tract Infection (UTI) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Novartis AG
• GlaxoSmithKline
• Dr. Reddy’s Laboratories Ltd.,
• Pfizer
• Roche
• AstraZeneca,
• Cipla
• Johnson & Johnson
• Bayer AG
• Teva Pharmaceutical Industries
• Boehringer Ingelheim
• Sanofi
• Lily
• Abbott
• JinShuiBao
• Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
• Sinopharm
• Borui Medicine
• Zhejiang Xianju Pharmaceutical
• Sichuan Guorui Pharmaceutical
• Hengrui Pharmaceutical

Market segment by Type, the product can be split into

• By Site of Infection
• Upper Urinary Tract Infection
• Lower Urinary Tract Infection
• By Clinical Symptoms
• Symptomatic Urinary Tract Infection
• Asymptomatic Urinary Tract Infection
• By Presence of Urinary Tract Abnormalities
• Simple/uncomplicated Urinary Tract Infection
• Complex Urinary Tract Infection

Market segment by Application, split into

• Hospitals
• Clinic
• Self-administered
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Urinary Tract Infection (UTI) status, future forecast, growth opportunity, key market and key players.
• To present the Urinary Tract Infection (UTI) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Urinary Tract Infection (UTI) are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Urinary Tract Infection (UTI) Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Urinary Tract Infection (UTI) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Upper Urinary Tract Infection
  1.4.3 Lower Urinary Tract Infection
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Urinary Tract Infection (UTI) Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Self-administered
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Urinary Tract Infection (UTI) Industry Impact
  1.6.1 How the Covid-19 is Affecting the Urinary Tract Infection (UTI) Industry
    1.6.1.1 Urinary Tract Infection (UTI) Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Urinary Tract Infection (UTI) Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Urinary Tract Infection (UTI) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Urinary Tract Infection (UTI) Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Urinary Tract Infection (UTI) Growth Trends by Regions
  2.2.1 Urinary Tract Infection (UTI) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Urinary Tract Infection (UTI) Historic Market Share by Regions (2015-2020)
  2.2.3 Urinary Tract Infection (UTI) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Urinary Tract Infection (UTI) Market Growth Strategy
  2.3.6 Primary Interviews with Key Urinary Tract Infection (UTI) Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Urinary Tract Infection (UTI) Players by Market Size
  3.1.1 Global Top Urinary Tract Infection (UTI) Players by Revenue (2015-2020)
  3.1.2 Global Urinary Tract Infection (UTI) Revenue Market Share by Players (2015-2020)
  3.1.3 Global Urinary Tract Infection (UTI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Urinary Tract Infection (UTI) Market Concentration Ratio
  3.2.1 Global Urinary Tract Infection (UTI) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Urinary Tract Infection (UTI) Revenue in 2019
3.3 Urinary Tract Infection (UTI) Key Players Head office and Area Served
3.4 Key Players Urinary Tract Infection (UTI) Product Solution and Service
3.5 Date of Enter into Urinary Tract Infection (UTI) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Urinary Tract Infection (UTI) Historic Market Size by Type (2015-2020)
4.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Urinary Tract Infection (UTI) Market Size by Application (2015-2020)
5.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Urinary Tract Infection (UTI) Market Size (2015-2020)
6.2 Urinary Tract Infection (UTI) Key Players in North America (2019-2020)
6.3 North America Urinary Tract Infection (UTI) Market Size by Type (2015-2020)
6.4 North America Urinary Tract Infection (UTI) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Urinary Tract Infection (UTI) Market Size (2015-2020)
7.2 Urinary Tract Infection (UTI) Key Players in Europe (2019-2020)
7.3 Europe Urinary Tract Infection (UTI) Market Size by Type (2015-2020)
7.4 Europe Urinary Tract Infection (UTI) Market Size by Application (2015-2020)

8 CHINA

8.1 China Urinary Tract Infection (UTI) Market Size (2015-2020)
8.2 Urinary Tract Infection (UTI) Key Players in China (2019-2020)
8.3 China Urinary Tract Infection (UTI) Market Size by Type (2015-2020)
8.4 China Urinary Tract Infection (UTI) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Urinary Tract Infection (UTI) Market Size (2015-2020)
9.2 Urinary Tract Infection (UTI) Key Players in Japan (2019-2020)
9.3 Japan Urinary Tract Infection (UTI) Market Size by Type (2015-2020)
9.4 Japan Urinary Tract Infection (UTI) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Urinary Tract Infection (UTI) Market Size (2015-2020)
10.2 Urinary Tract Infection (UTI) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Urinary Tract Infection (UTI) Market Size by Type (2015-2020)
10.4 Southeast Asia Urinary Tract Infection (UTI) Market Size by Application (2015-2020)

11 INDIA

11.1 India Urinary Tract Infection (UTI) Market Size (2015-2020)
11.2 Urinary Tract Infection (UTI) Key Players in India (2019-2020)
11.3 India Urinary Tract Infection (UTI) Market Size by Type (2015-2020)
11.4 India Urinary Tract Infection (UTI) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Urinary Tract Infection (UTI) Market Size (2015-2020)
12.2 Urinary Tract Infection (UTI) Key Players in Central & South America (2019-2020)
12.3 Central & South America Urinary Tract Infection (UTI) Market Size by Type (2015-2020)
12.4 Central & South America Urinary Tract Infection (UTI) Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Novartis AG
  13.1.1 Novartis AG Company Details
  13.1.2 Novartis AG Business Overview and Its Total Revenue
  13.1.3 Novartis AG Urinary Tract Infection (UTI) Introduction
  13.1.4 Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2015-2020))
  13.1.5 Novartis AG Recent Development
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Details
  13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Urinary Tract Infection (UTI) Introduction
  13.2.4 GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  13.2.5 GlaxoSmithKline Recent Development
13.3 Dr. Reddy’s Laboratories Ltd.,
  13.3.1 Dr. Reddy’s Laboratories Ltd., Company Details
  13.3.2 Dr. Reddy’s Laboratories Ltd., Business Overview and Its Total Revenue
  13.3.3 Dr. Reddy’s Laboratories Ltd., Urinary Tract Infection (UTI) Introduction
  13.3.4 Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  13.3.5 Dr. Reddy’s Laboratories Ltd., Recent Development
13.4 Pfizer
  13.4.1 Pfizer Company Details
  13.4.2 Pfizer Business Overview and Its Total Revenue
  13.4.3 Pfizer Urinary Tract Infection (UTI) Introduction
  13.4.4 Pfizer Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  13.4.5 Pfizer Recent Development
13.5 Roche
  13.5.1 Roche Company Details
  13.5.2 Roche Business Overview and Its Total Revenue
  13.5.3 Roche Urinary Tract Infection (UTI) Introduction
  13.5.4 Roche Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  13.5.5 Roche Recent Development
13.6 AstraZeneca,
  13.6.1 AstraZeneca, Company Details
  13.6.2 AstraZeneca, Business Overview and Its Total Revenue
  13.6.3 AstraZeneca, Urinary Tract Infection (UTI) Introduction
  13.6.4 AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  13.6.5 AstraZeneca, Recent Development
13.7 Cipla
  13.7.1 Cipla Company Details
  13.7.2 Cipla Business Overview and Its Total Revenue
  13.7.3 Cipla Urinary Tract Infection (UTI) Introduction
  13.7.4 Cipla Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  13.7.5 Cipla Recent Development
13.8 Johnson & Johnson
  13.8.1 Johnson & Johnson Company Details
  13.8.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.8.3 Johnson & Johnson Urinary Tract Infection (UTI) Introduction
  13.8.4 Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  13.8.5 Johnson & Johnson Recent Development
13.9 Bayer AG
  13.9.1 Bayer AG Company Details
  13.9.2 Bayer AG Business Overview and Its Total Revenue
  13.9.3 Bayer AG Urinary Tract Infection (UTI) Introduction
  13.9.4 Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  13.9.5 Bayer AG Recent Development
13.10 Teva Pharmaceutical Industries
  13.10.1 Teva Pharmaceutical Industries Company Details
  13.10.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
  13.10.3 Teva Pharmaceutical Industries Urinary Tract Infection (UTI) Introduction
  13.10.4 Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  13.10.5 Teva Pharmaceutical Industries Recent Development
13.11 Boehringer Ingelheim
  10.11.1 Boehringer Ingelheim Company Details
  10.11.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  10.11.3 Boehringer Ingelheim Urinary Tract Infection (UTI) Introduction
  10.11.4 Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.11.5 Boehringer Ingelheim Recent Development
13.12 Sanofi
  10.12.1 Sanofi Company Details
  10.12.2 Sanofi Business Overview and Its Total Revenue
  10.12.3 Sanofi Urinary Tract Infection (UTI) Introduction
  10.12.4 Sanofi Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.12.5 Sanofi Recent Development
13.13 Lily
  10.13.1 Lily Company Details
  10.13.2 Lily Business Overview and Its Total Revenue
  10.13.3 Lily Urinary Tract Infection (UTI) Introduction
  10.13.4 Lily Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.13.5 Lily Recent Development
13.14 Abbott
  10.14.1 Abbott Company Details
  10.14.2 Abbott Business Overview and Its Total Revenue
  10.14.3 Abbott Urinary Tract Infection (UTI) Introduction
  10.14.4 Abbott Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.14.5 Abbott Recent Development
13.15 JinShuiBao
  10.15.1 JinShuiBao Company Details
  10.15.2 JinShuiBao Business Overview and Its Total Revenue
  10.15.3 JinShuiBao Urinary Tract Infection (UTI) Introduction
  10.15.4 JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.15.5 JinShuiBao Recent Development
13.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
  10.16.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
  10.16.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview and Its Total Revenue
  10.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Urinary Tract Infection (UTI) Introduction
  10.16.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
13.17 Sinopharm
  10.17.1 Sinopharm Company Details
  10.17.2 Sinopharm Business Overview and Its Total Revenue
  10.17.3 Sinopharm Urinary Tract Infection (UTI) Introduction
  10.17.4 Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.17.5 Sinopharm Recent Development
13.18 Borui Medicine
  10.18.1 Borui Medicine Company Details
  10.18.2 Borui Medicine Business Overview and Its Total Revenue
  10.18.3 Borui Medicine Urinary Tract Infection (UTI) Introduction
  10.18.4 Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.18.5 Borui Medicine Recent Development
13.19 Zhejiang Xianju Pharmaceutical
  10.19.1 Zhejiang Xianju Pharmaceutical Company Details
  10.19.2 Zhejiang Xianju Pharmaceutical Business Overview and Its Total Revenue
  10.19.3 Zhejiang Xianju Pharmaceutical Urinary Tract Infection (UTI) Introduction
  10.19.4 Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.19.5 Zhejiang Xianju Pharmaceutical Recent Development
13.20 Sichuan Guorui Pharmaceutical
  10.20.1 Sichuan Guorui Pharmaceutical Company Details
  10.20.2 Sichuan Guorui Pharmaceutical Business Overview and Its Total Revenue
  10.20.3 Sichuan Guorui Pharmaceutical Urinary Tract Infection (UTI) Introduction
  10.20.4 Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.20.5 Sichuan Guorui Pharmaceutical Recent Development
13.21 Hengrui Pharmaceutical
  10.21.1 Hengrui Pharmaceutical Company Details
  10.21.2 Hengrui Pharmaceutical Business Overview and Its Total Revenue
  10.21.3 Hengrui Pharmaceutical Urinary Tract Infection (UTI) Introduction
  10.21.4 Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2015-2020)
  10.21.5 Hengrui Pharmaceutical Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Urinary Tract Infection (UTI) Key Market Segments
Table 2. Key Players Covered: Ranking by Urinary Tract Infection (UTI) Revenue
Table 3. Ranking of Global Top Urinary Tract Infection (UTI) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Urinary Tract Infection (UTI) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Upper Urinary Tract Infection
Table 6. Key Players of Lower Urinary Tract Infection
Table 7. COVID-19 Impact Global Market: (Four Urinary Tract Infection (UTI) Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Urinary Tract Infection (UTI) Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Urinary Tract Infection (UTI) Players to Combat Covid-19 Impact
Table 12. Global Urinary Tract Infection (UTI) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Urinary Tract Infection (UTI) Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Urinary Tract Infection (UTI) Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Urinary Tract Infection (UTI) Market Share by Regions (2015-2020)
Table 16. Global Urinary Tract Infection (UTI) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Urinary Tract Infection (UTI) Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Urinary Tract Infection (UTI) Market Growth Strategy
Table 22. Main Points Interviewed from Key Urinary Tract Infection (UTI) Players
Table 23. Global Urinary Tract Infection (UTI) Revenue by Players (2015-2020) (Million US$)
Table 24. Global Urinary Tract Infection (UTI) Market Share by Players (2015-2020)
Table 25. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection (UTI) as of 2019)
Table 26. Global Urinary Tract Infection (UTI) by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Urinary Tract Infection (UTI) Product Solution and Service
Table 29. Date of Enter into Urinary Tract Infection (UTI) Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Urinary Tract Infection (UTI) Market Size by Type (2015-2020) (Million US$)
Table 32. Global Urinary Tract Infection (UTI) Market Size Share by Type (2015-2020)
Table 33. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2021-2026)
Table 34. Global Urinary Tract Infection (UTI) Market Size Share by Application (2015-2020)
Table 35. Global Urinary Tract Infection (UTI) Market Size by Application (2015-2020) (Million US$)
Table 36. Global Urinary Tract Infection (UTI) Market Size Share by Application (2021-2026)
Table 37. North America Key Players Urinary Tract Infection (UTI) Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Urinary Tract Infection (UTI) Market Share (2019-2020)
Table 39. North America Urinary Tract Infection (UTI) Market Size by Type (2015-2020) (Million US$)
Table 40. North America Urinary Tract Infection (UTI) Market Share by Type (2015-2020)
Table 41. North America Urinary Tract Infection (UTI) Market Size by Application (2015-2020) (Million US$)
Table 42. North America Urinary Tract Infection (UTI) Market Share by Application (2015-2020)
Table 43. Europe Key Players Urinary Tract Infection (UTI) Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Urinary Tract Infection (UTI) Market Share (2019-2020)
Table 45. Europe Urinary Tract Infection (UTI) Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Urinary Tract Infection (UTI) Market Share by Type (2015-2020)
Table 47. Europe Urinary Tract Infection (UTI) Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Urinary Tract Infection (UTI) Market Share by Application (2015-2020)
Table 49. China Key Players Urinary Tract Infection (UTI) Revenue (2019-2020) (Million US$)
Table 50. China Key Players Urinary Tract Infection (UTI) Market Share (2019-2020)
Table 51. China Urinary Tract Infection (UTI) Market Size by Type (2015-2020) (Million US$)
Table 52. China Urinary Tract Infection (UTI) Market Share by Type (2015-2020)
Table 53. China Urinary Tract Infection (UTI) Market Size by Application (2015-2020) (Million US$)
Table 54. China Urinary Tract Infection (UTI) Market Share by Application (2015-2020)
Table 55. Japan Key Players Urinary Tract Infection (UTI) Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Urinary Tract Infection (UTI) Market Share (2019-2020)
Table 57. Japan Urinary Tract Infection (UTI) Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Urinary Tract Infection (UTI) Market Share by Type (2015-2020)
Table 59. Japan Urinary Tract Infection (UTI) Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Urinary Tract Infection (UTI) Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Urinary Tract Infection (UTI) Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Urinary Tract Infection (UTI) Market Share (2019-2020)
Table 63. Southeast Asia Urinary Tract Infection (UTI) Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Urinary Tract Infection (UTI) Market Share by Type (2015-2020)
Table 65. Southeast Asia Urinary Tract Infection (UTI) Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Urinary Tract Infection (UTI) Market Share by Application (2015-2020)
Table 67. India Key Players Urinary Tract Infection (UTI) Revenue (2019-2020) (Million US$)
Table 68. India Key Players Urinary Tract Infection (UTI) Market Share (2019-2020)
Table 69. India Urinary Tract Infection (UTI) Market Size by Type (2015-2020) (Million US$)
Table 70. India Urinary Tract Infection (UTI) Market Share by Type (2015-2020)
Table 71. India Urinary Tract Infection (UTI) Market Size by Application (2015-2020) (Million US$)
Table 72. India Urinary Tract Infection (UTI) Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Urinary Tract Infection (UTI) Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Urinary Tract Infection (UTI) Market Share (2019-2020)
Table 75. Central & South America Urinary Tract Infection (UTI) Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Urinary Tract Infection (UTI) Market Share by Type (2015-2020)
Table 77. Central & South America Urinary Tract Infection (UTI) Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Urinary Tract Infection (UTI) Market Share by Application (2015-2020)
Table 79. Novartis AG Company Details
Table 80. Novartis AG Business Overview
Table 81. Novartis AG Product
Table 82. Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 83. Novartis AG Recent Development
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Product
Table 87. GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline Recent Development
Table 89. Dr. Reddy’s Laboratories Ltd., Company Details
Table 90. Dr. Reddy’s Laboratories Ltd., Business Overview
Table 91. Dr. Reddy’s Laboratories Ltd., Product
Table 92. Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 93. Dr. Reddy’s Laboratories Ltd., Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. AstraZeneca, Company Details
Table 105. AstraZeneca, Business Overview
Table 106. AstraZeneca, Product
Table 107. AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 108. AstraZeneca, Recent Development
Table 109. Cipla Company Details
Table 110. Cipla Business Overview
Table 111. Cipla Product
Table 112. Cipla Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 113. Cipla Recent Development
Table 114. Johnson & Johnson Business Overview
Table 115. Johnson & Johnson Product
Table 116. Johnson & Johnson Company Details
Table 117. Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 118. Johnson & Johnson Recent Development
Table 119. Bayer AG Company Details
Table 120. Bayer AG Business Overview
Table 121. Bayer AG Product
Table 122. Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 123. Bayer AG Recent Development
Table 124. Teva Pharmaceutical Industries Company Details
Table 125. Teva Pharmaceutical Industries Business Overview
Table 126. Teva Pharmaceutical Industries Product
Table 127. Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 128. Teva Pharmaceutical Industries Recent Development
Table 129. Boehringer Ingelheim Company Details
Table 130. Boehringer Ingelheim Business Overview
Table 131. Boehringer Ingelheim Product
Table 132. Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 133. Boehringer Ingelheim Recent Development
Table 134. Sanofi Company Details
Table 135. Sanofi Business Overview
Table 136. Sanofi Product
Table 137. Sanofi Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 138. Sanofi Recent Development
Table 139. Lily Company Details
Table 140. Lily Business Overview
Table 141. Lily Product
Table 142. Lily Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 143. Lily Recent Development
Table 144. Abbott Company Details
Table 145. Abbott Business Overview
Table 146. Abbott Product
Table 147. Abbott Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 148. Abbott Recent Development
Table 149. JinShuiBao Company Details
Table 150. JinShuiBao Business Overview
Table 151. JinShuiBao Product
Table 152. JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 153. JinShuiBao Recent Development
Table 154. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
Table 155. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 156. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Product
Table 157. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 158. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 159. Sinopharm Company Details
Table 160. Sinopharm Business Overview
Table 161. Sinopharm Product
Table 162. Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 163. Sinopharm Recent Development
Table 164. Borui Medicine Company Details
Table 165. Borui Medicine Business Overview
Table 166. Borui Medicine Product
Table 167. Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 168. Borui Medicine Recent Development
Table 169. Zhejiang Xianju Pharmaceutical Company Details
Table 170. Zhejiang Xianju Pharmaceutical Business Overview
Table 171. Zhejiang Xianju Pharmaceutical Product
Table 172. Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 173. Zhejiang Xianju Pharmaceutical Recent Development
Table 174. Sichuan Guorui Pharmaceutical Company Details
Table 175. Sichuan Guorui Pharmaceutical Business Overview
Table 176. Sichuan Guorui Pharmaceutical Product
Table 177. Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 178. Sichuan Guorui Pharmaceutical Recent Development
Table 179. Hengrui Pharmaceutical Company Details
Table 180. Hengrui Pharmaceutical Business Overview
Table 181. Hengrui Pharmaceutical Product
Table 182. Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2015-2020) (Million US$)
Table 183. Hengrui Pharmaceutical Recent Development
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Urinary Tract Infection (UTI) Market Share by Type: 2020 VS 2026
Figure 2. Upper Urinary Tract Infection Features
Figure 3. Lower Urinary Tract Infection Features
Figure 4. Global Urinary Tract Infection (UTI) Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Self-administered Case Studies
Figure 8. Others Case Studies
Figure 9. Urinary Tract Infection (UTI) Report Years Considered
Figure 10. Global Urinary Tract Infection (UTI) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Urinary Tract Infection (UTI) Market Share by Regions: 2020 VS 2026
Figure 12. Global Urinary Tract Infection (UTI) Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Urinary Tract Infection (UTI) Market Share by Players in 2019
Figure 15. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection (UTI) as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Urinary Tract Infection (UTI) Revenue in 2019
Figure 17. North America Urinary Tract Infection (UTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Urinary Tract Infection (UTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Urinary Tract Infection (UTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Urinary Tract Infection (UTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Urinary Tract Infection (UTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Urinary Tract Infection (UTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Urinary Tract Infection (UTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Novartis AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 26. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. GlaxoSmithKline Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 28. Dr. Reddy’s Laboratories Ltd., Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Dr. Reddy’s Laboratories Ltd., Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 30. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Pfizer Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Roche Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 34. AstraZeneca, Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. AstraZeneca, Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 36. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Cipla Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 38. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Johnson & Johnson Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 40. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Bayer AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 42. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Teva Pharmaceutical Industries Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 44. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Boehringer Ingelheim Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 46. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Sanofi Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 48. Lily Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Lily Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 50. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Abbott Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 52. JinShuiBao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. JinShuiBao Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 54. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 56. Sinopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sinopharm Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 58. Borui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Borui Medicine Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 60. Zhejiang Xianju Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 62. Sichuan Guorui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Sichuan Guorui Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed